Adams Kendra bought CCCC
February 14, 2024 · Form 4 insider transaction
Adams Kendra bought 165,300 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
165,300
Price
$0.00
Total value
N/A
InsiderAdams Kendra
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2024
Filing dateFebruary 15, 2024
Shares owned after165,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024.